XBiotech Inc

NASDAQ:XBIT   10:18:27 AM EDT
11.10
+0.38 (+3.54%)
Products

XBiotech Says FDA Approves Xbiotech’s IND In Rheumatology

Published: 12/13/2021 13:15 GMT
XBiotech Inc (XBIT) - FDA Approves Xbiotech’s Ind in Rheumatology.
Xbiotech Inc - Will First Launch Natrunix in a Phase I Study to Evaluate Dosing for Subcutaneous Injections.
Xbiotech Inc - Once Preliminary Dosing Has Been Established, Company Plans to Proceed With Phase Ii Studies in Ra.